The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intravesical (IVe) valrubicin for treatment of carcinoma in situ (CIS) of the bladder: Use in clinical practice.
Michael S. Cookson
Consultant or Advisory Role - Endo Pharmaceuticals; Spectrum Pharmaceuticals; US HIFU
Research Funding - Endo Pharmaceuticals; Spectrum Pharmaceuticals
Christine Francis Lihou
Employment or Leadership Position - Endo Pharmaceuticals
Stock Ownership - Endo Pharmaceuticals
Samira Q. Harper
Employment or Leadership Position - Endo Pharmaceuticals
Stock Ownership - Endo Pharmaceuticals
Zhihui Lang
Employment or Leadership Position - Endo Pharmaceuticals
Stock Ownership - Endo Pharmaceuticals